Dr. Angelo Sambunaris, MD

  • Alpharetta, GA
  • Psychiatrist
NPI1164541256
Part D claims, 2024
420
Publications
9
Clinical trials
5
Industry payments
$38,697
State license
1
Practice address
5755 N Point Pkwy Ste 256, Alpharetta, GA 30022-1174
Practice phone
Call (770) 817-9200
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Sambunaris' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Angelo Sambunaris is a psychiatrist in Alpharetta, Georgia

Dr. Sambunaris practices in Alpharetta, Georgia.

Dr. Sambunaris' NPI, 1164541256, was assigned on March 28, 2007. Dr. Sambunaris holds Georgia license GA46321.

NPI and contact details
NPI enumeration date
March 28, 2007
NPI status
Active
Practice phone
(770) 817-9200
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dr. Angelo Sambunaris' practice address is in Alpharetta, Georgia

Dr. Sambunaris' practice address in the NPI Registry is 5755 N Point Pkwy Ste 256, Alpharetta, GA 30022-1174. The practice phone is (770) 817-9200.

  • NPI Registry address
    5755 N Point Pkwy Ste 256, Alpharetta, GA 30022-1174Phone(770) 817-9200

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dmand AI tracks the EHR system at Dr. Angelo Sambunaris' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sambunaris practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Sambunaris' practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Sambunaris practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Angelo Sambunaris is one of 929 psychiatrists in Georgia

Psychiatry is Dr. Sambunaris' primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Sambunaris is licensed in Georgia.

Specialties and state licenses

  • Psychiatry, GeorgiaPrimaryLicense GA46321 · taxonomy 2084P0800X

Psychiatrists near Dr. Sambunaris

Counts of psychiatrists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Angelo Sambunaris' patients have a median age of 52

Across all payers, Dmand AI patient panel data puts Dr. Sambunaris' median patient age at 52, with 67% women.

Dr. Sambunaris' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 52

Patient panel by sex, all payers

  • Women67%
  • Men33%

Source: Dmand AI Patient Panel Data

Dr. Angelo Sambunaris wrote 420 Medicare Part D claims in 2024

In 2024, Dr. Sambunaris wrote 420 Medicare Part D claims for 28 patients. 99% of them were for generic drugs. CMS names the drug for 358 of them, across 9 drugs with 11 or more claims each, at $4,021 in total drug cost. In 2023, CMS named 286 claims across 8 drugs.

Part D claims, 2024420
Drugs named by CMS9
Total drug cost$4,021
Part D patients28

Dr. Sambunaris' Part D claims by kind of drug, 2024

  • Generic416 claims99%
  • Brand-name and other4 claims1%

Dr. Sambunaris' most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Sambunaris' Part D claims, 2024

  • Antipsychotics, patients 65 and over8%32 of 420 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2862024: 35825%

Drugs named by CMS: 9 in 2024, 8 in 2023.

See all prescribing by Dr. Sambunaris

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find psychiatrists like Dr. Sambunaris by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Angelo Sambunaris has 9 publications on record

Dmand AI links 9 papers to Dr. Sambunaris, published from 2013 to 2016. 2013 was the busiest year, with 2. The most frequent topics are Double-Blind Method, Antidepressive Agents and Depressive Disorder, Major. Dr. Sambunaris has published most often in Int Clin Psychopharmacol. Dr. Sambunaris' most frequent co-authors are William Greenberg, MD, Robert A. Lasser, MD and Madhukar Hariprasad Trivedi, MD.

Papers9
Years published2013 to 2016

Topics Dr. Sambunaris writes about most

  • Double-Blind Method
  • Antidepressive Agents
  • Depressive Disorder, Major
  • Psychiatric Status Rating Scales
  • Cyclopropanes
  • Delayed-Action Preparations
  • Milnacipran
  • Adrenergic Uptake Inhibitors

Dr. Sambunaris' most frequent co-authors

Recent publications by Dr. Sambunaris

See all 9 publications and co-authors

See who Dr. Sambunaris researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Sambunaris works with, so you can find a warm path to the right psychiatrists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Angelo Sambunaris has worked on 5 clinical trials

Dmand AI links Dr. Sambunaris to 5 clinical trials. Conditions studied include Depressive Disorder, Major, Depressive Disorder and Borderline Personality Disorder. Open Payments lists research payments to Dr. Sambunaris that name 4 trials.

Conditions in Dr. Sambunaris' trials

  • Depressive Disorder, Major
  • Depressive Disorder
  • Borderline Personality Disorder
  • Fibromyalgia
  • Migraine Disorders

Investigators on the most trials with Dr. Sambunaris

Recent clinical trials with Dr. Sambunaris

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Angelo Sambunaris received $38,697 in industry payments from 2016 to 2025

CMS Open Payments shows 108 general payments to Dr. Sambunaris from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Janssen Research & Development, LLC paid the most, $30,339. It also lists 106 research payments totaling $273,434 from 2016 to 2019, naming 4 clinical trials.

General payments to Dr. Sambunaris by program year, 2016 to 2025

General payments to Dr. Sambunaris by kind, 2016 to 2025

$38.7Kin total
  • Consulting fees$27,04070%
  • Travel and lodging$8,32122%
  • Food and beverage$3,3209%
  • Education$170%

Companies that paid Dr. Sambunaris the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Sambunaris

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Angelo Sambunaris's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Angelo Sambunaris

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Angelo Sambunaris' NPI number?

Dr. Angelo Sambunaris' NPI number is 1164541256. It was assigned on March 28, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Angelo Sambunaris?

Dr. Angelo Sambunaris is a psychiatrist in Alpharetta, Georgia. The primary specialty in the NPI Registry is Psychiatry Physician (taxonomy code 2084P0800X).

Where does Dr. Angelo Sambunaris practice?

Dr. Sambunaris practices at 5755 N Point Pkwy Ste 256, Alpharetta, GA 30022-1174.

What is Dr. Angelo Sambunaris' office phone number?

The practice phone on file for Dr. Sambunaris is (770) 817-9200.

What is Dr. Angelo Sambunaris' medical license number?

Dr. Sambunaris holds Georgia license GA46321.

What drugs does Dr. Angelo Sambunaris prescribe most?

In 2024 Medicare Part D data, Dr. Sambunaris' most prescribed drugs by claims were Lorazepam, Duloxetine HCl and Dextroamphetamine-Amphetamine.

Has Dr. Angelo Sambunaris received payments from drug or device companies?

CMS Open Payments shows $38,697 in general payments to Dr. Sambunaris from 18 companies from 2016 to 2025. The largest total came from Janssen Research & Development, LLC.

How long has Dr. Angelo Sambunaris been practicing?

Dr. Sambunaris' NPI was assigned in 2007.

Does Dr. Angelo Sambunaris do research?

Dmand AI links 9 publications to Dr. Sambunaris, published from 2013 to 2016. Dr. Sambunaris has worked on 5 clinical trials.

Who does Dr. Angelo Sambunaris publish with?

Dr. Sambunaris' most frequent co-authors are William Greenberg, MD (2 shared papers), Robert A. Lasser, MD (2 shared papers) and Madhukar Hariprasad Trivedi, MD (2 shared papers).

Selling to psychiatry practices?

See psychiatrists in Georgia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)